BIIB vs DHIL · P/E 21, rev $9.89B vs P/E 9.8, rev $151.1M
Biogen Inc (BIIB) versus Diamond Hill Investment Group Inc (DHIL) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Diamond Hill Investment Group Inc (DHIL) is a asset management company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported DHIL revenue for 2024-12-31 was $151.1M. Net income was $43.2M. Revenue was up 10.5% from 2023-12-31 to 2024-12-31. DHIL currently screens at market cap $473.3M and trailing P/E 9.8.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. DHIL currently screens at market cap $473.3M and trailing P/E 9.8.
Not investment advice. Open the BIIB and DHIL stock pages for the full models.
Not investment advice.